<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Idiopathic intracranial hypertension (pseudotumor cerebri): Epidemiology and pathogenesis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew G Lee, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Wall, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan Trobe, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Janet L Wilterdink, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 28, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Idiopathic intracranial hypertension (IIH), also called pseudotumor cerebri, is a disorder defined by clinical criteria that include symptoms and signs isolated to those produced by increased intracranial pressure (ICP; eg, headache, papilledema, vision loss), elevated ICP with normal cerebrospinal fluid (CSF) composition, and no other cause of intracranial hypertension evident on neuroimaging or other evaluations [<a href="#rid1">1</a>].</p><p>While once called benign intracranial hypertension, to distinguish it from secondary intracranial hypertension produced by a neoplastic malignancy, it is not a benign disorder. Many patients with IIH suffer from headaches, which may be disabling, and there is a risk of severe, permanent vision loss.</p><p>While the pathogenesis of IIH is unknown, risk factors have been identified and many theories advanced as to its cause. The epidemiology and pathogenesis of IIH will be reviewed here. The clinical features, diagnosis, prognosis, and treatment of this disorder are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/5253.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Prognosis and treatment"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H456571163"><span class="h2">Incidence</span><span class="headingEndMark"> — </span>The annual incidence of IIH is 1 to 2 per 100,000 population [<a href="#rid2">2,3</a>]. There is a higher incidence in females with obesity between the ages of 15 and 44 years (4 to 21 per 100,000) [<a href="#rid3">3,4</a>]. The highest incidence, 28 per 100,000 per year, was reported in Ireland [<a href="#rid5">5</a>].</p><p>The incidence and prevalence of IIH are rising [<a href="#rid6">6</a>]; whether this is related to the obesity epidemic or other reasons is uncertain.</p><p class="headingAnchor" id="H3"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>IIH is a disorder that primarily affects females of childbearing age who are overweight [<a href="#rid3">3,4,7-11</a>]. In a prospective study of 50 consecutively diagnosed IIH patients, 92 percent were females with a mean age of 31 years (range 11 to 58 years), and 94 percent were obese [<a href="#rid10">10</a>]. Other case series in different geographic areas and ethnic groups report similar findings [<a href="#rid4">4,11-16</a>].</p><p>IIH can also occur in males and in patients who are not overweight; it is also reported in children as young as four months and in older patients (up to 88 years) [<a href="#rid15">15,17-20</a>]. However, when symptoms occur in one of the less typical patient groups, the evaluation for secondary causes of intracranial hypertension is particularly important. (See  <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis", section on 'Differential diagnosis'</a>.)</p><p>The annual incidence of IIH in children younger than 17 years old has been estimated as 0.63 per 100,000 children in the United States [<a href="#rid21">21</a>]. Risk factors are different in prepubertal children compared with adults. There is no female preponderance in young patients [<a href="#rid17">17,22-30</a>]. Also, prepubertal children with IIH are not more likely to be obese than the general age-matched population [<a href="#rid22">22,23,26,27,29,30</a>]. </p><p>In one report, older patients (greater than 44 years) with IIH were also more often male and less often obese than patients with IIH in the more typical age range [<a href="#rid31">31</a>]. Males with IIH have a similar age distribution as females, and obesity remains a risk factor but may be less prevalent in males than in females with IIH [<a href="#rid12">12,18</a>].</p><p>Recent weight gain may be a risk factor for IIH, according to case-control studies [<a href="#rid8">8,10,11,32</a>]. In one series, there was an average reported weight gain of 1.8 kg over the two months preceding symptom onset [<a href="#rid10">10</a>]; in another series, there was an average 20 pound weight gain over the preceding year compared with an average weight loss of 1.2 pounds in controls [<a href="#rid11">11</a>].</p><p>In the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT), 5 percent of patients reported a family history of IIH [<a href="#rid16">16</a>]. As this frequency is higher than the prevalence of IIH in persons with obesity, a genetic component for IIH is suggested.</p><p class="headingAnchor" id="H4"><span class="h2">Associated conditions</span><span class="headingEndMark"> — </span>Several systemic diseases, drugs, vitamin deficiencies and excesses, anemia [<a href="#rid33">33,34</a>], and hereditary conditions have been reported to be associated with IIH, but that association is uncommon. </p><p>The true link between these conditions and IIH is uncertain in many cases. In case-control studies, the prevalence of menstrual irregularities, pregnancy, antibiotic use, iron deficiency anemia, thyroid dysfunction, and oral contraceptive use was no different among cases versus controls [<a href="#rid8">8,11</a>]. However, these studies were small (40 to 50 patients), which may have limited their ability to detect true associations.</p><p class="headingAnchor" id="H5"><span class="h3">Medications</span><span class="headingEndMark"> — </span>A number of medications and other exogenous substances have been linked to IIH. In some cases, the connection may be anecdotal. In other cases, evidence that supports a true association includes temporal proximity between drug initiation and IIH in a substantial number of patients, resolution with drug cessation or dose lowering, lack of recurrence off medication, and/or reemergence of IIH with drug rechallenge. Such evidence appears to exist for growth hormone, tetracyclines, and retinoids.</p><p class="bulletIndent1"><span class="glyph">●</span>Growth hormone appears to be associated with IIH in a dose-related manner [<a href="#rid35">35-41</a>]. One 2007 study estimated the incidence of IIH in children treated with growth hormone to be 27.7 per 100,000 treatment years. This complication usually develops within one year of initiation of therapy but may appear after several years [<a href="#rid42">42</a>]. IIH generally subsides with stopping growth hormone therapy; resuming therapy at a lower dose is often successful. Other specific treatments for IIH may also be required [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/z/d/html/5843.html" rel="external">"Treatment of growth hormone deficiency in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tetracyclines, including <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">minocycline</a> and <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a>, have been linked in a number of cases to IIH, but other risk factors are often present [<a href="#rid43">43-52</a>]. When it occurs, IIH often appears shortly after onset of treatment (within a few weeks to months), but a more delayed onset has been described. Drug withdrawal appears to be sufficient for treatment in some patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypervitaminosis A from excessive dietary intake has been a long-known cause of IIH [<a href="#rid43">43,53</a>]. Other retinoids used in the treatment of dermatologic conditions and cancer therapy, <a class="drug drug_general" data-topicid="9262" href="/z/d/drug information/9262.html" rel="external">all-trans retinoic acid</a>, retinol, <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">isotretinoin</a>, etretinate, and tretinoin have also been reported to be associated with IIH [<a href="#rid43">43,44,48,54-58</a>].</p><p></p><p>More limited, possibly anecdotal evidence links other medications with IIH:</p><p class="bulletIndent1"><span class="glyph">●</span>Thyroid replacement [<a href="#rid25">25,59-61</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Corticosteroid withdrawal [<a href="#rid31">31,62,63</a>]</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">Lithium</a> [<a href="#rid64">64-67</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Nalidixic acid [<a href="#rid26">26,68</a>]</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9704" href="/z/d/drug information/9704.html" rel="external">Nitrofurantoin</a> [<a href="#rid69">69,70</a>]</p><p></p><p class="headingAnchor" id="H6"><span class="h3">Systemic illnesses</span><span class="headingEndMark"> — </span>In addition to obesity, systemic illnesses reportedly associated with IIH include:</p><p class="bulletIndent1"><span class="glyph">●</span>Addison disease [<a href="#rid71">71,72</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Hypoparathyroidism [<a href="#rid73">73</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Anemia, usually severe [<a href="#rid15">15,33,74,75</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Sleep apnea [<a href="#rid15">15,16,19,76,77</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Systemic lupus erythematosus (SLE) [<a href="#rid78">78-80</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Behçet syndrome [<a href="#rid81">81,82</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Polycystic ovary syndrome [<a href="#rid83">83</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Coagulation disorders [<a href="#rid83">83-86</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Uremia [<a href="#rid87">87</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Hypovitaminosis A [<a href="#rid88">88-91</a>]</p><p></p><p>The pathogenic mechanisms associating these conditions with IIH are uncertain, and in some cases, the apparent association may be indirect or spurious. As an example, sleep apnea is associated with obesity and therefore may be secondarily associated with IIH. In SLE, cases of apparent IIH may be due to occult cerebral venous thrombosis (related to inflammation of the venous sinus or hypercoagulability) or to corticosteroid withdrawal [<a href="#rid78">78</a>]. Other hypercoagulable syndromes, sarcoidosis, and Behçet syndrome may also be associated with IIH by causing secondary intracranial hypertension via occult venous sinus thrombosis. (See  <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Although many theories for IIH have been proposed, the precise pathogenesis of IIH remains unknown. Any theory must account for the high incidence of IIH in obese females of childbearing years. Proposed etiologies include cerebral venous outflow abnormalities (eg, venous stenoses and venous hypertension); increased cerebrospinal fluid (CSF) outflow resistance at the level of either the arachnoid granulations or CSF lymphatic drainage sites; obesity-related increased abdominal and intracranial venous pressure; altered sodium and water retention mechanisms; and abnormalities of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> metabolism [<a href="#rid92">92</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Intracranial venous hypertension</span><span class="headingEndMark"> — </span>Elevated intracranial venous pressure is postulated both as a primary mechanism and as a "final common pathway" for IIH. This theory is supported by the similar clinical appearances of IIH and secondary intracranial hypertension due to cerebral venous thrombosis and other causes of obstructed venous outflow. Some patients thought to have IIH have been later discovered to have one of these conditions [<a href="#rid81">81,93-95</a>]. (See  <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis", section on 'Differential diagnosis'</a>.)</p><p>Although several authors have reported cerebral venous outflow abnormalities on magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) in patients with IIH, there is some disagreement as to the frequency or the significance of these findings [<a href="#rid20">20,96,97</a>]. Clear venous sinus thrombosis has definite clinicopathologic significance, but apparent bilateral venous sinus narrowing or stenosis is now known to be a biomarker of increased intracranial pressure (ICP) [<a href="#rid98">98</a>]. Differentiation of venous stenosis from flow-related abnormalities, especially on noncontrast MRV, can be difficult, as flow-related artifacts can mimic venous sinus stenoses or even be mistaken for sinus thrombosis. These issues can sometimes be resolved with postcontrast MRV. Literature that suggests a high frequency of venous sinus abnormalities in patients with IIH must be viewed with caution.</p><p>Cerebral venous sinus structural abnormalities were systematically identified in a series of 29 patients with IIH using a specialized MRV technique, auto-triggered elliptic-centric-ordered three-dimensional gadolinium-enhanced MRV (ATECO MRV) [<a href="#rid99">99</a>]. Masked readers detected substantial bilateral sinovenous stenoses in 27 of 29 patients compared with 4 of 59 controls, corresponding to a sensitivity and specificity of 93 percent. The investigators speculated that congenital narrowing of the venous sinus might be a primary cause of IIH or alternatively a secondary, but potentially contributing, factor. In the latter scenario, increased CSF pressure compresses the transverse sinuses leading to the stenoses, which in turn would exacerbate the increased ICP, potentially bringing the patient to clinical presentation.</p><p>Other evidence leaves open the question of whether these apparent venous abnormalities are a secondary or a primary (causative) phenomenon. One study documented high intracranial venous sinus pressures in patients with IIH that were reduced by removal of CSF [<a href="#rid100">100</a>]. This finding implies that increased cerebral venous sinus pressure and apparent stenosis in IIH is caused by the elevated ICP and is not its cause. Other reports have also documented reversal of apparent transverse sinus stenosis after CSF shunting [<a href="#rid101">101-106</a>]. By contrast, other case series have documented persistent transverse sinus stenosis in patients with IIH whose CSF pressure has normalized and an overall poor correlation between the severity of the venous abnormalities and the degree of pressure elevation or severity of clinical findings [<a href="#rid107">107,108</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Other theories</span><span class="headingEndMark"> — </span>There is evidence that obesity increases intraabdominal pressure, pleural pressure, cardiac filling pressure, and central venous pressure and may lead to increased intracranial venous pressure and IIH [<a href="#rid109">109</a>]. Limited support for this theory comes from a report of seven obese females with IIH who reported subjective symptom relief with the use of an externally applied device that lowered abdominal pressure [<a href="#rid110">110</a>]. However, this mechanism does not account for the sex difference in IIH, the lack of increased incidence in pregnancy, and the cases of IIH in thin patients [<a href="#rid111">111,112</a>].</p><p>Cerebral edema was one of the earliest proposed mechanisms for IIH and had pathologic support in one case series [<a href="#rid113">113</a>]. However, subsequent pathologic and MRI studies have not found evidence of cerebral edema in patients with IIH [<a href="#rid114">114-117</a>]. A link between IIH and altered sodium and water retention was suggested by another report in which 77 percent of patients with IIH had evidence of peripheral edema and 80 percent had orthostatic retention of sodium and water [<a href="#rid118">118</a>]. Impaired excretion after water or <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> load in the upright posture was noted in patients with IIH with orthostatic edema compared with lean patients with IIH and obese controls without IIH. However, the precise mechanisms linking orthostatic changes and IIH were not defined, and many patients with IIH do not have these sodium and water abnormalities.</p><p>Case reports of IIH occurring in association with <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> intoxication have suggested a role for vitamin A in the pathogenesis of IIH [<a href="#rid43">43,53</a>]. Elevated serum vitamin A, retinol, and retinol-binding protein levels have been reported in some patients with IIH [<a href="#rid119">119,120</a>]. In other studies, higher CSF vitamin A, retinol, and retinol-binding protein levels have been found in patients with IIH compared with controls [<a href="#rid121">121-123</a>]. One case-control study concluded vitamin A toxicity was an unlikely cause of IIH [<a href="#rid124">124</a>]. </p><p>Other causes of impaired CSF absorption or increased CSF production have also been postulated as an etiology of IIH. As an example, one hypothesis proposes that microthrombosis in the sagittal sinus may block CSF absorption in the arachnoid granulations there, even in the absence of a thrombosis of sufficient size to be seen on neuroimaging studies [<a href="#rid83">83,125</a>]. Conditions that obstruct venous outflow (venous sinus thrombosis), impair CSF absorption (subarachnoid hemorrhage or infectious meningitis), and are associated with CSF overproduction (choroid plexus papilloma) can produce a syndrome similar to IIH. (See  <a class="medical medical_review" href="/z/d/html/5257.html" rel="external">"Idiopathic intracranial hypertension (pseudotumor cerebri): Clinical features and diagnosis", section on 'Differential diagnosis'</a>.)</p><p>Sleep apnea can be a complication of obesity and may play a role in IIH, perhaps in males in particular [<a href="#rid19">19,126</a>]. Hypercarbia may produce elevated ICP through vasodilation. Papilledema occurs in approximately 1 percent of patients with sleep apnea [<a href="#rid127">127,128</a>]. One study found that 14 of 37 patients with IIH had a sleep disturbance, and of these, 13 had evidence of sleep apnea or upper airway resistance syndrome [<a href="#rid77">77</a>]. In another report, a patient with IIH underwent ICP monitoring with pulse oximetry to reveal that apneic episodes were associated with marked elevations of ICP [<a href="#rid129">129</a>].</p><p>Several studies have looked at the pathophysiology of obesity and its complications as a basis for IIH. Leptin is a protein secreted by adipose cells in proportion to total body fat content. Higher serum leptin levels were found in 15 obese patients with IIH compared with 16 obese and 15 nonobese controls [<a href="#rid130">130</a>]. The pathophysiologic consequences of this finding are not known. Other studies of other adipokines, leptin, and the gastric hormone, ghrelin, have not consistently found an association with IIH [<a href="#rid125">125,131</a>].</p><p>Few studies have examined the potential role of sex hormones in IIH. In one study of eight males with IIH, two had abnormal estradiol levels, four had abnormal follicle-stimulating and luteinizing hormone levels, and seven had low testosterone levels [<a href="#rid132">132</a>].</p><p class="headingAnchor" id="H2401016"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/82902.html" rel="external">"Patient education: Idiopathic intracranial hypertension (pseudotumor cerebri) (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H10"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence and risk factors </strong>– The incidence of idiopathic intracranial hypertension (IIH) in the general population is 1 to 2 per 100,000 population and is 2 to 20 times higher in the primary risk group: overweight females of childbearing years. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Associated medications and medical illnesses</strong> – A long list of medications has been reported to be associated with IIH. The evidence linking growth hormone treatment, retinoids, and <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">tetracycline</a> antibiotics is strongest; however, the mechanisms by which these might produce IIH is not known. (See <a class="local">'Medications'</a> above.)</p><p></p><p class="bulletIndent1">Other than obesity, the association between other medical conditions and IIH is not proven. (See <a class="local">'Systemic illnesses'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Theories of pathogenesis</strong> – The pathogenesis of IIH is unknown. Much attention has been placed on the association of IIH with venous sinus stenosis. However, most of the evidence at present suggests that apparent venous sinus narrowing is secondary to increased intracranial pressure (ICP) and is not the primary cause in most cases. (See <a class="local">'Intracranial venous hypertension'</a> above.)</p><p></p><p class="bulletIndent1">Other theories include increased cerebrospinal fluid (CSF) outflow resistance, obesity-related increased abdominal and intracranial venous pressure, altered sodium and water retention mechanisms, and abnormalities of <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">vitamin A</a> metabolism. (See <a class="local">'Other theories'</a> above.)</p><p></p><p class="headingAnchor" id="H4082684973"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Claudia Prospero Ponce, MD, and Aroucha Vickers, MD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59:1492.</a></li><li><a class="nounderline abstract_t">Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45:875.</a></li><li><a class="nounderline abstract_t">Radhakrishnan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol 1993; 50:78.</a></li><li><a class="nounderline abstract_t">Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001; 21:12.</a></li><li><a class="nounderline abstract_t">McCluskey G, Mulholland DA, McCarron P, McCarron MO. Idiopathic Intracranial Hypertension in the Northwest of Northern Ireland: Epidemiology and Clinical Management. Neuroepidemiology 2015; 45:34.</a></li><li><a class="nounderline abstract_t">Curry WT Jr, Butler WE, Barker FG 2nd. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 2005; 57:97.</a></li><li><a class="nounderline abstract_t">Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39:461.</a></li><li><a class="nounderline abstract_t">Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990; 47:315.</a></li><li><a class="nounderline abstract_t">Jain N, Rosner F. Idiopathic intracranial hypertension: report of seven cases. Am J Med 1992; 93:391.</a></li><li><a class="nounderline abstract_t">Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114 ( Pt 1A):155.</a></li><li><a class="nounderline abstract_t">Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991; 41:239.</a></li><li><a class="nounderline abstract_t">Kesler A, Goldhammer Y, Gadoth N. Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases. J Neuroophthalmol 2001; 21:15.</a></li><li><a class="nounderline abstract_t">Bruce BB, Preechawat P, Newman NJ, et al. Racial differences in idiopathic intracranial hypertension. Neurology 2008; 70:861.</a></li><li><a class="nounderline abstract_t">Galvin JA, Van Stavern GP. Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center. J Neurol Sci 2004; 223:157.</a></li><li><a class="nounderline abstract_t">Bruce BB, Kedar S, Van Stavern GP, et al. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology 2010; 74:1827.</a></li><li><a class="nounderline abstract_t">Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol 2014; 71:693.</a></li><li><a class="nounderline abstract_t">Soler D, Cox T, Bullock P, et al. Diagnosis and management of benign intracranial hypertension. Arch Dis Child 1998; 78:89.</a></li><li><a class="nounderline abstract_t">Digre KB, Corbett JJ. Pseudotumor cerebri in men. Arch Neurol 1988; 45:866.</a></li><li><a class="nounderline abstract_t">Lee AG, Golnik K, Kardon R, et al. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002; 109:482.</a></li><li><a class="nounderline abstract_t">Johnston I, Kollar C, Dunkley S, et al. Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci 2002; 9:273.</a></li><li><a class="nounderline abstract_t">Gillson N, Jones C, Reem RE, et al. Incidence and Demographics of Pediatric Intracranial Hypertension. Pediatr Neurol 2017; 73:42.</a></li><li><a class="nounderline abstract_t">Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999; 52:870.</a></li><li><a class="nounderline abstract_t">Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999; 127:178.</a></li><li><a class="nounderline abstract_t">Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci 1997; 24:219.</a></li><li><a class="nounderline abstract_t">Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol 1992; 37:155.</a></li><li><a class="nounderline abstract_t">Scott IU, Siatkowski RM, Eneyni M, et al. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol 1997; 124:253.</a></li><li><a class="nounderline abstract_t">Genizi J, Lahat E, Zelnik N, et al. Childhood-onset idiopathic intracranial hypertension: relation of sex and obesity. Pediatr Neurol 2007; 36:247.</a></li><li><a class="nounderline abstract_t">Warman R. Management of pseudotumor cerebri in children. Int Pediatr 2000; 15:147.</a></li><li><a class="nounderline abstract_t">Distelmaier F, Sengler U, Messing-Juenger M, et al. Pseudotumor cerebri as an important differential diagnosis of papilledema in children. Brain Dev 2006; 28:190.</a></li><li><a class="nounderline abstract_t">Per H, Canpolat M, Gümüş H, et al. Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev 2013; 35:561.</a></li><li><a class="nounderline abstract_t">Bandyopadhyay S, Jacobson DM. Clinical features of late-onset pseudotumor cerebri fulfilling the modified dandy criteria. J Neuroophthalmol 2002; 22:9.</a></li><li><a class="nounderline abstract_t">Salpietro V, Chimenz R, Arrigo T, Ruggieri M. Pediatric idiopathic intracranial hypertension and extreme childhood obesity: a role for weight gain. J Pediatr 2013; 162:1084.</a></li><li><a class="nounderline abstract_t">Biousse V, Rucker JC, Vignal C, et al. Anemia and papilledema. Am J Ophthalmol 2003; 135:437.</a></li><li><a class="nounderline abstract_t">Mollan SP, Ball AK, Sinclair AJ, et al. Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management. Eur Neurol 2009; 62:105.</a></li><li><a class="nounderline abstract_t">Blethen SL. Complications of growth hormone therapy in children. Curr Opin Pediatr 1995; 7:466.</a></li><li><a class="nounderline abstract_t">Francois I, Casteels I, Silberstein J, et al. Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy. Eur J Pediatr 1997; 156:69.</a></li><li><a class="nounderline abstract_t">Koller EA, Stadel BV, Malozowski SN. Papilledema in 15 renally compromised patients treated with growth hormone. Pediatr Nephrol 1997; 11:451.</a></li><li><a class="nounderline abstract_t">Malozowski S, Tanner LA, Wysowski DK, et al. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr 1995; 126:996.</a></li><li><a class="nounderline abstract_t">Rogers AH, Rogers GL, Bremer DL, McGregor ML. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology 1999; 106:1186.</a></li><li><a class="nounderline abstract_t">Maneatis T, Baptista J, Connelly K, Blethen S. Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 2000; 13 Suppl 2:1035.</a></li><li><a class="nounderline abstract_t">Reeves GD, Doyle DA. Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship? J Pediatr Endocrinol Metab 2002; 15 Suppl 2:723.</a></li><li><a class="nounderline abstract_t">Vischi A, Guerriero S, Giancipoli G, et al. Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment. Eur J Ophthalmol 2006; 16:178.</a></li><li><a class="nounderline abstract_t">Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol 2005; 6:29.</a></li><li><a class="nounderline abstract_t">Moskowitz Y, Leibowitz E, Ronen M, Aviel E. Pseudotumor cerebri induced by vitamin A combined with minocycline. Ann Ophthalmol 1993; 25:306.</a></li><li><a class="nounderline abstract_t">Sirdofsky M, Kattah J, Macedo P. Intracranial hypertension in a dieting patient. J Neuroophthalmol 1994; 14:9.</a></li><li><a class="nounderline abstract_t">Ang ER, Zimmerman JC, Malkin E. Pseudotumor cerebri secondary to minocycline intake. J Am Board Fam Pract 2002; 15:229.</a></li><li><a class="nounderline abstract_t">Chiu AM, Chuenkongkaew WL, Cornblath WT, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998; 126:116.</a></li><li><a class="nounderline abstract_t">Friedman DI, Gordon LK, Egan RA, et al. Doxycycline and intracranial hypertension. Neurology 2004; 62:2297.</a></li><li><a class="nounderline abstract_t">Gardner K, Cox T, Digre KB. Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review. Neurology 1995; 45:6.</a></li><li><a class="nounderline abstract_t">Kesler A, Goldhammer Y, Hadayer A, Pianka P. The outcome of pseudotumor cerebri induced by tetracycline therapy. Acta Neurol Scand 2004; 110:408.</a></li><li><a class="nounderline abstract_t">Mochizuki K, Takahashi T, Kano M, et al. Pseudotumor cerebri induced by minocycline therapy for acne vulgaris. Jpn J Ophthalmol 2002; 46:668.</a></li><li><a class="nounderline abstract_t">Fraser CL, Biousse V, Newman NJ. Minocycline-induced fulminant intracranial hypertension. Arch Neurol 2012; 69:1067.</a></li><li><a class="nounderline abstract_t">Donahue SP. Recurrence of idiopathic intracranial hypertension after weight loss: the carrot craver. Am J Ophthalmol 2000; 130:850.</a></li><li><a class="nounderline abstract_t">Alemayehu W. Pseudotumor cerebri (toxic effect of the "magic bullet"). Ethiop Med J 1995; 33:265.</a></li><li><a class="nounderline abstract_t">Sharieff GQ, Hanten K. Pseudotumor cerebri and hypercalcemia resulting from vitamin A toxicity. Ann Emerg Med 1996; 27:518.</a></li><li><a class="nounderline abstract_t">Colucciello M. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia. Arch Ophthalmol 2003; 121:1064.</a></li><li><a class="nounderline abstract_t">Yeh YC, Tang HF, Fang IM. Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia. Jpn J Ophthalmol 2006; 50:295.</a></li><li><a class="nounderline abstract_t">Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin-associated intracranial hypertension. Ophthalmology 2004; 111:1248.</a></li><li><a class="nounderline abstract_t">Serratrice J, Granel B, Conrath J, et al. Benign intracranial hypertension and thyreostimulin suppression hormonotherapy. Am J Ophthalmol 2002; 134:910.</a></li><li><a class="nounderline abstract_t">Campos SP, Olitsky S. Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism. Clin Pediatr (Phila) 1995; 34:334.</a></li><li><a class="nounderline abstract_t">Raghavan S, DiMartino-Nardi J, Saenger P, Linder B. Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr 1997; 130:478.</a></li><li><a class="nounderline abstract_t">Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol 1994; 117:352.</a></li><li><a class="nounderline abstract_t">Rickels MR, Nichols CW. Pseudotumor cerebri in patients with Cushing's disease. Endocr Pract 2004; 10:492.</a></li><li><a class="nounderline abstract_t">Ames D, Wirshing WC, Cokely HT, Lo LL. The natural course of pseudotumor cerebri in lithium-treated patients. J Clin Psychopharmacol 1994; 14:286.</a></li><li><a class="nounderline abstract_t">Dommisse J. Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 1991; 52:239.</a></li><li><a class="nounderline abstract_t">Hexom B, Barthel RP. Lithium and pseudotumor cerebri. J Am Acad Child Adolesc Psychiatry 2004; 43:247.</a></li><li><a class="nounderline abstract_t">Levine SH, Puchalski C. Pseudotumor cerebri associated with lithium therapy in two patients. J Clin Psychiatry 1990; 51:251.</a></li><li><a class="nounderline abstract_t">Mukherjee A, Dutta P, Lahiri M, et al. Benign intracranial hypertension after nalidixic acid overdose in infants. Lancet 1990; 335:1602.</a></li><li><a class="nounderline abstract_t">Mushet GR. Pseudotumor and nitrofurantoin therapy. Arch Neurol 1977; 34:257.</a></li><li><a class="nounderline abstract_t">Francis PJ, Haywood S, Rigden S, et al. Benign intracranial hypertension in children following renal transplantation. Pediatr Nephrol 2003; 18:1265.</a></li><li><a class="nounderline abstract_t">Condulis N, Germain G, Charest N, et al. Pseudotumor cerebri: a presenting manifestation of Addison's disease. Clin Pediatr (Phila) 1997; 36:711.</a></li><li><a class="nounderline abstract_t">Alexandrakis G, Filatov V, Walsh T. Pseudotumor cerebri in a 12-year-old boy with Addison's disease. Am J Ophthalmol 1993; 116:650.</a></li><li><a class="nounderline abstract_t">Sheldon RS, Becker WJ, Hanley DA, Culver RL. Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association. Can J Neurol Sci 1987; 14:622.</a></li><li><a class="nounderline abstract_t">Segal L, Discepola M. Idiopathic intracranial hypertension and sickle cell disease: two case reports. Can J Ophthalmol 2005; 40:764.</a></li><li><a class="nounderline abstract_t">Nazir SA, Siatkowski RM. Pseudotumor cerebri in idiopathic aplastic anemia. J AAPOS 2003; 7:71.</a></li><li><a class="nounderline abstract_t">Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol 2000; 118:1626.</a></li><li><a class="nounderline abstract_t">Marcus DM, Lynn J, Miller JJ, et al. Sleep disorders: a risk factor for pseudotumor cerebri? J Neuroophthalmol 2001; 21:121.</a></li><li><a class="nounderline abstract_t">Dave S, Longmuir R, Shah VA, et al. Intracranial hypertension in systemic lupus erythematosus. Semin Ophthalmol 2008; 23:127.</a></li><li><a class="nounderline abstract_t">Hershko AY, Berkun Y, Mevorach D, et al. Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience. Semin Arthritis Rheum 2008; 38:110.</a></li><li><a class="nounderline abstract_t">Green L, Vinker S, Amital H, et al. Pseudotumor cerebri in systemic lupus erythematosus. Semin Arthritis Rheum 1995; 25:103.</a></li><li><a class="nounderline abstract_t">Celebisoy N, Seçil Y, Akyürekli O. Pseudotumor cerebri: etiological factors, presenting features and prognosis in the western part of Turkey. Acta Neurol Scand 2002; 106:367.</a></li><li><a class="nounderline abstract_t">Palacio E, Rodero L, Pascual J. Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndrome. Headache 2004; 44:436.</a></li><li><a class="nounderline abstract_t">Glueck CJ, Iyengar S, Goldenberg N, et al. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med 2003; 142:35.</a></li><li><a class="nounderline abstract_t">Kesler A, Ellis MH, Reshef T, et al. Idiopathic intracranial hypertension and anticardiolipin antibodies. J Neurol Neurosurg Psychiatry 2000; 68:379.</a></li><li><a class="nounderline abstract_t">Leker RR, Steiner I. Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension. Arch Neurol 1998; 55:817.</a></li><li><a class="nounderline abstract_t">Sussman J, Leach M, Greaves M, et al. Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension. J Neurol Neurosurg Psychiatry 1997; 62:229.</a></li><li><a class="nounderline abstract_t">Chang D, Nagamoto G, Smith WE. Benign intracranial hypertension and chronic renal failure. Cleve Clin J Med 1992; 59:419.</a></li><li><a class="nounderline abstract_t">Dotan G, Goldstein M, Stolovitch C, Kesler A. Pediatric Pseudotumor Cerebri Associated With Low Serum Levels of Vitamin A. J Child Neurol 2013; 28:1370.</a></li><li><a class="nounderline abstract_t">Obeid M, Price J, Sun L, et al. Facial palsy and idiopathic intracranial hypertension in twins with cystic fibrosis and hypovitaminosis A. Pediatr Neurol 2011; 44:150.</a></li><li><a class="nounderline abstract_t">Panozzo G, Babighian S, Bonora A. Association of xerophthalmia, flecked retina, and pseudotumor cerebri caused by hypovitaminosis A. Am J Ophthalmol 1998; 125:708.</a></li><li><a class="nounderline abstract_t">Lucidi V, Di Capua M, Rosati P, et al. Benign intracranial hypertension in an older child with cystic fibrosis. Pediatr Neurol 1993; 9:494.</a></li><li><a class="nounderline abstract_t">Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2012; 83:488.</a></li><li><a class="nounderline abstract_t">Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999; 53:1537.</a></li><li><a class="nounderline abstract_t">Lin A, Foroozan R, Danesh-Meyer HV, et al. Occurrence of cerebral venous sinus thrombosis in patients with presumed idiopathic intracranial hypertension. Ophthalmology 2006; 113:2281.</a></li><li><a class="nounderline abstract_t">Tehindrazanarivelo A, Evrard S, Schaison M, et al. Prospective study of cerebral sinus venous thrombosis in patients presenting with benign intracranial hypertension. Cerebrovasc Dis 1992; 2:22.</a></li><li><a class="nounderline abstract_t">Lee AG, Brazis PW. Magnetic resonance venography in idiopathic pseudotumor cerebri. J Neuroophthalmol 2000; 20:12.</a></li><li><a class="nounderline abstract_t">Higgins JN, Tipper G, Varley M, Pickard JD. Transverse sinus stenoses in benign intracranial hypertension demonstrated on CT venography. Br J Neurosurg 2005; 19:137.</a></li><li><a class="nounderline abstract_t">Bono F, Lupo MR, Lavano A, et al. Cerebral MR venography of transverse sinuses in subjects with normal CSF pressure. Neurology 2003; 61:1267.</a></li><li><a class="nounderline abstract_t">Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003; 60:1418.</a></li><li><a class="nounderline abstract_t">King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002; 58:26.</a></li><li><a class="nounderline abstract_t">Simister R, Bowler JV, Wilson PL, et al. Transverse venous sinus stenosis and intracranial hypertension: evidence for which comes first. J Neurol 2008; 255:601.</a></li><li><a class="nounderline abstract_t">McGonigal A, Bone I, Teasdale E. Resolution of transverse sinus stenosis in idiopathic intracranial hypertension after L-P shunt. Neurology 2004; 62:514.</a></li><li><a class="nounderline abstract_t">Higgins JN, Pickard JD. Lateral sinus stenoses in idiopathic intracranial hypertension resolving after CSF diversion. Neurology 2004; 62:1907.</a></li><li><a class="nounderline abstract_t">Rohr A, Dörner L, Stingele R, et al. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2007; 28:656.</a></li><li><a class="nounderline abstract_t">De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci 2005; 25:342.</a></li><li><a class="nounderline abstract_t">Baryshnik DB, Farb RI. Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology 2004; 62:1445.</a></li><li><a class="nounderline abstract_t">Bono F, Giliberto C, Mastrandrea C, et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology 2005; 65:1090.</a></li><li><a class="nounderline abstract_t">Riggeal BD, Bruce BB, Saindane AM, et al. Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis. Neurology 2013; 80:289.</a></li><li><a class="nounderline abstract_t">Sugerman HJ, DeMaria EJ, Felton WL 3rd, et al. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997; 49:507.</a></li><li><a class="nounderline abstract_t">Sugerman HJ, Felton III WL 3rd, Sismanis A, et al. Continuous negative abdominal pressure device to treat pseudotumor cerebri. Int J Obes Relat Metab Disord 2001; 25:486.</a></li><li><a class="nounderline abstract_t">Friedman DI. Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2006; 26:61.</a></li><li><a class="nounderline abstract_t">Digre KB, Varner MW, Corbett JJ. Pseudotumor cerebri and pregnancy. Neurology 1984; 34:721.</a></li><li><a class="nounderline abstract_t">Sahs AL, Joynt RJ. Brain swelling of unknown cause. Neurology 1954; 6:791.</a></li><li><a class="nounderline abstract_t">Wall M, Dollar JD, Sadun AA, Kardon R. Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema. Arch Neurol 1995; 52:141.</a></li><li><a class="nounderline abstract_t">Bastin ME, Sinha S, Farrall AJ, et al. Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study. J Neurol Neurosurg Psychiatry 2003; 74:1693.</a></li><li><a class="nounderline abstract_t">Bicakci K, Bicakci S, Aksungur E. Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension. Acta Neurol Scand 2006; 114:193.</a></li><li><a class="nounderline abstract_t">Owler BK, Higgins JN, Péna A, et al. Diffusion tensor imaging of benign intracranial hypertension: absence of cerebral oedema. Br J Neurosurg 2006; 20:79.</a></li><li><a class="nounderline abstract_t">Friedman DI, Streeten DH. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology 1998; 50:1099.</a></li><li><a class="nounderline abstract_t">Jacobson DM, Berg R, Wall M, et al. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology 1999; 53:1114.</a></li><li><a class="nounderline abstract_t">Selhorst JB, Kulkantrakorn K, Corbett JJ, et al. Retinol-binding protein in idiopathic intracranial hypertension (IIH). J Neuroophthalmol 2000; 20:250.</a></li><li><a class="nounderline abstract_t">Warner JE, Bernstein PS, Yemelyanov A, et al. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol 2002; 52:647.</a></li><li><a class="nounderline abstract_t">Tabassi A, Salmasi AH, Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology 2005; 64:1893.</a></li><li><a class="nounderline abstract_t">Warner JE, Larson AJ, Bhosale P, et al. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension. J Neuroophthalmol 2007; 27:258.</a></li><li><a class="nounderline abstract_t">Libien J, Kupersmith MJ, Blaner W, et al. Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. J Neurol Sci 2017; 372:78.</a></li><li><a class="nounderline abstract_t">Ooi LY, Walker BR, Bodkin PA, Whittle IR. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis? Br J Neurosurg 2008; 22:187.</a></li><li><a class="nounderline abstract_t">Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology 2009; 72:304.</a></li><li><a class="nounderline abstract_t">Lee SSY, Nilagiri VK, Mackey DA. Sleep and eye disease: A review. Clin Exp Ophthalmol 2022; 50:334.</a></li><li><a class="nounderline abstract_t">Wong B, Fraser CL. Obstructive Sleep Apnea in Neuro-Ophthalmology. J Neuroophthalmol 2019; 39:370.</a></li><li><a class="nounderline abstract_t">Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997; 49:734.</a></li><li><a class="nounderline abstract_t">Lampl Y, Eshel Y, Kessler A, et al. Serum leptin level in women with idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2002; 72:642.</a></li><li><a class="nounderline abstract_t">Subramanian PS, Goldenberg-Cohen N, Shukla S, et al. Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2004; 138:109.</a></li><li class="breakAll">Lee A, Kardon R, Wall M, Schlechte J. Endocrinologic abnormalities in pseudotumor cerebri in men. In: 28th Annual North American Neuro-Ophthalmology Society Meeting, Copper Mountain, CO 2002.</li></ol></div><div id="topicVersionRevision">Topic 5254 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12455560" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diagnostic criteria for idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3395261" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8418804" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11315973" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Epidemiology of idiopathic intracranial hypertension in Israel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26201454" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Idiopathic Intracranial Hypertension in the Northwest of Northern Ireland: Epidemiology and Clinical Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15987545" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7103794" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2310315" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The search for causes of idiopathic intracranial hypertension. A preliminary case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1415302" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Idiopathic intracranial hypertension: report of seven cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1998880" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Idiopathic intracranial hypertension. A prospective study of 50 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1992368" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11315974" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Do men with pseudomotor cerebri share the same characteristics as women? A retrospective review of 141 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18332344" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Racial differences in idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15337617" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Clinical characterization of idiopathic intracranial hypertension at the Detroit Medical Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20513819" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Atypical idiopathic intracranial hypertension: normal BMI and older patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24756302" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9534686" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Diagnosis and management of benign intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3395260" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pseudotumor cerebri in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11874748" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Sleep apnea and intracranial hypertension in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12093133" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28668233" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Incidence and Demographics of Pediatric Intracranial Hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10078746" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Idiopathic intracranial hypertension: relation of age and obesity in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10030560" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9276106" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Pediatric pseudotumor cerebri: descriptive epidemiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1475750" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pediatric pseudotumor cerebri (idiopathic intracranial hypertension).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9262557" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Idiopathic intracranial hypertension in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17437908" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Childhood-onset idiopathic intracranial hypertension: relation of sex and obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Management of pseudotumor cerebri in children</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16368210" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Pseudotumor cerebri as an important differential diagnosis of papilledema in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22981259" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11937898" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical features of late-onset pseudotumor cerebri fulfilling the modified dandy criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23452583" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Pediatric idiopathic intracranial hypertension and extreme childhood obesity: a role for weight gain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12654358" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Anemia and papilledema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19521086" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7581653" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Complications of growth hormone therapy in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9007496" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9260244" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Papilledema in 15 renally compromised patients treated with growth hormone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7776116" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10366091" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Pseudotumor cerebri in children receiving recombinant human growth hormone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11086659" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Growth hormone safety update from the National Cooperative Growth Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12092686" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16496267" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15675888" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Medication-induced intracranial hypertension in dermatology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8239326" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pseudotumor cerebri induced by vitamin A combined with minocycline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8032485" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Intracranial hypertension in a dieting patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12038730" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Pseudotumor cerebri secondary to minocycline intake.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9683157" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Minocycline treatment and pseudotumor cerebri syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15210900" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Doxycycline and intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7824136" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case reports and review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15527455" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The outcome of pseudotumor cerebri induced by tetracycline therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12543195" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Pseudotumor cerebri induced by minocycline therapy for acne vulgaris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22490325" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Minocycline-induced fulminant intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11124317" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Recurrence of idiopathic intracranial hypertension after weight loss: the carrot craver.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8674493" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pseudotumor cerebri (toxic effect of the "magic bullet").</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8604874" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Pseudotumor cerebri and hypercalcemia resulting from vitamin A toxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12860824" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16767393" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Pseudotumor cerebri caused by all-trans-retinoic acid treatment for acute promyelocytic leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15177980" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Isotretinoin-associated intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12470764" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Benign intracranial hypertension and thyreostimulin suppression hormonotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7656515" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9063429" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8129010" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16033722" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pseudotumor cerebri in patients with Cushing's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7962691" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The natural course of pseudotumor cerebri in lithium-treated patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2033032" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Pseudotumor cerebri associated with lithium therapy in two patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15076255" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Lithium and pseudotumor cerebri.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2347863" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Pseudotumor cerebri associated with lithium therapy in two patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1972527" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Benign intracranial hypertension after nalidixic acid overdose in infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/843266" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Pseudotumor and nitrofurantoin therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14586682" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Benign intracranial hypertension in children following renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9415840" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Pseudotumor cerebri: a presenting manifestation of Addison's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8238233" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Pseudotumor cerebri in a 12-year-old boy with Addison's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3690435" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Hypoparathyroidism and pseudotumor cerebri: an infrequent clinical association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16391644" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Idiopathic intracranial hypertension and sickle cell disease: two case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12690375" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Pseudotumor cerebri in idiopathic aplastic anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11115256" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Papilledema and obstructive sleep apnea syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11450902" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Sleep disorders: a risk factor for pseudotumor cerebri?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18320479" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Intracranial hypertension in systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18221986" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8578310" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Pseudotumor cerebri in systemic lupus erythematosus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12460143" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Pseudotumor cerebri: etiological factors, presenting features and prognosis in the western part of Turkey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15147251" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12878984" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10675226" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Idiopathic intracranial hypertension and anticardiolipin antibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9626773" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9069476" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Potentially prothrombotic abnormalities of coagulation in benign intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1525975" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Benign intracranial hypertension and chronic renal failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23364653" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Pediatric Pseudotumor Cerebri Associated With Low Serum Levels of Vitamin A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21215918" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Facial palsy and idiopathic intracranial hypertension in twins with cystic fibrosis and hypovitaminosis A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9625560" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Association of xerophthalmia, flecked retina, and pseudotumor cerebri caused by hypovitaminosis A.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7605562" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Benign intracranial hypertension in an older child with cystic fibrosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22423118" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Update on the pathophysiology and management of idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10534264" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Isolated intracranial hypertension as the only sign of cerebral venous thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17157135" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Occurrence of cerebral venous sinus thrombosis in patients with presumed idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Prospective study of cerebral sinus venous thrombosis in patients presenting with benign intracranial hypertension</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10770498" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Magnetic resonance venography in idiopathic pseudotumor cerebri.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16120516" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Transverse sinus stenoses in benign intracranial hypertension demonstrated on CT venography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14610135" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Cerebral MR venography of transverse sinuses in subjects with normal CSF pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12743224" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11781401" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Manometry combined with cervical puncture in idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17994308" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Transverse venous sinus stenosis and intracranial hypertension: evidence for which comes first.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14872049" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Resolution of transverse sinus stenosis in idiopathic intracranial hypertension after L-P shunt.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15159514" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Lateral sinus stenoses in idiopathic intracranial hypertension resolving after CSF diversion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17416816" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Reversibility of venous sinus obstruction in idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15729498" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15111701" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16217064" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Transverse sinus stenoses persist after normalization of the CSF pressure in IIH.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23269597" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9270586" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11319651" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Continuous negative abdominal pressure device to treat pseudotumor cerebri.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16518170" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6539432" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Pseudotumor cerebri and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Brain swelling of unknown cause</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7848121" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Idiopathic intracranial hypertension. Lack of histologic evidence for cerebral edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14638893" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16911348" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16753621" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Diffusion tensor imaging of benign intracranial hypertension: absence of cerebral oedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9566401" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10496276" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Serum vitamin A concentration is elevated in idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11130751" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Retinol-binding protein in idiopathic intracranial hypertension (IIH).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12402264" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15955940" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18090557" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28017254" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18348012" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18923135" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Idiopathic intracranial hypertension in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35263016" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Sleep and eye disease: A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30300256" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Obstructive Sleep Apnea in Neuro-Ophthalmology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9305333" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Lumboperitoneal shunting for pseudotumor cerebri.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11971053" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Serum leptin level in women with idiopathic intracranial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15234288" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri).</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
